University Hospital Lille Overview

Trial Radar AI Insights

Lille University Hospital

University Hospital Lille stands as a leading public teaching hospital in northern France, renowned for its extensive involvement in clinical research that advances treatments for complex diseases, offering trial participants access to cutting-edge therapies through its robust network of specialized centers. With a strong emphasis on patient-centered care, it drives innovation in areas like metabolic disorders and neurosciences, contributing significantly to European clinical trial landscapes by sponsoring and collaborating on studies that improve outcomes for diverse patient populations.

• Institution Profile: Founded 1798 · Lille, France · Public · chru-lille.fr
• Therapeutic Strengths: Metabolic and cardiovascular diseases; Neurosciences; Cancer
• Research standing: World's Best Hospitals, Rank #26 (Newsweek, 2025); National Referral Center for Rare Systemic Autoimmune and Auto-inflammatory Diseases (CeRAINO), designated by French Ministry of Health since 2007
• Partnerships: Université de Lille; Inserm (French National Institute of Health and Medical Research); CNRS (French National Centre for Scientific Research); Institut Pasteur de Lille; Eurasanté

Clinical Research Infrastructure

University Hospital Lille operates a comprehensive clinical research ecosystem anchored in its multiple affiliated hospitals and specialized institutes, facilitating seamless integration of basic science with patient care. As a key hub for translational research, it supports trials across phases by leveraging advanced facilities for diagnostics, imaging, and intervention delivery, ensuring high standards of safety and efficacy in study conduct.

Key components include flagship hospitals such as Hôpital Claude Huriez for general and specialized care, Hôpital Jeanne de Flandre focused on women's and children's health, and Hôpital Roger Salengro dedicated to neurosurgery and neurology. The infrastructure extends to disease-specific centers of excellence, including the Lille Inflammation Research International Center for immunology studies, Lille Neurosciences & Cognition for brain disorder research, and the Institute for Translational Research in Inflammation, which bridges laboratory findings to clinical applications. Additionally, the Clinical Investigation Centre for Innovative Technology (CIC-IT 1403) enhances trial capabilities through expertise in medical devices and digital tools.

Key Specialties and Therapeutic Focus

University Hospital Lille excels in metabolic and cardiovascular diseases, targeting conditions like diabetes, obesity, and heart failure through genomic and pharmacological approaches, including small molecules and biologics to address underlying mechanisms such as insulin resistance. In neurosciences, the hospital leads efforts against neurodegenerative disorders like frontotemporal dementia and stroke, employing interventions such as neuropharmacology and advanced imaging like MRI for biomarker identification and prognosis. Cancer research emphasizes oncology, particularly rare tumors like Merkel cell carcinoma and glioblastoma, utilizing procedures, radiation, and innovative therapies like photodynamic treatments.

• Therapeutic modalities include drugs (e.g., prednisolone for inflammatory conditions), procedures (e.g., endoscopic surgeries), genetic analyses, and devices for remote monitoring.
• Leading specialists: François Pattou (endocrine and bariatric surgery); David Devos (neurology and neuropharmacology); Philippe Froguel (genomics of diabetes and obesity); Régis Bordet (medical pharmacology and neurology); Frédéric Gottrand (pediatric gastroenterology, hepatology, and nutrition).
• Notable treatment breakthroughs: Completed Phase II trial (Dosindygo) for photodynamic therapy in glioblastoma (2023), demonstrating improved tumor targeting and survival rates in this aggressive brain cancer.

University Hospital Lille Clinical Trials Landscape

Trial StatisticsApply Below Filters

University Hospital Lille leads 114 active clinical trials as of September 2025, encompassing recruiting, not yet recruiting, and active not recruiting statuses, with a total enrollment of 88,391 participants across these studies, reflecting its substantial role in advancing medical research. These trials span 478 locations, predominantly in France, and involve an average of 775 participants per trial, with a focus on adult (100 trials) and older adult (92 trials) populations, alongside 23 pediatric studies. Key conditions driving enrollment include esophageal diseases (15,000 participants) and metabolic diseases (10,000), often conducted at affiliated sites like Hôpital Claude Huriez.

Key Clinical Trial Updates

Recent activity includes seven trials updated in the past month, signaling ongoing momentum in areas like obesity and multiple sclerosis. A standout development is the 2023 completion of the Phase II Dosindygo trial for glioblastoma photodynamic therapy, which showed promising efficacy and paves the way for Phase III initiation. Upcoming milestones involve primary completion dates for Phase II and III studies in cancer and neurosciences by late 2026, alongside potential regulatory submissions to the European Medicines Agency for novel anti-inflammatory agents.

Trial Innovation

University Hospital Lille incorporates patient-centric designs in its trials, such as adaptive protocols for metabolic disease studies that adjust based on interim biomarkers like eosinophil levels. The CIC-IT 1403 enables integration of digital health tools, including remote monitoring via wearables for post-stroke recovery and real-world evidence collection in longevity research. Decentralized elements, like virtual assessments in neurodevelopmental disorder trials, enhance accessibility while utilizing AI-driven data analysis for prognostic insights.

Clinical Trial Participation Guide

Use Trial Radar's participation assistant to simplify trial details, preview steps with What to Expect, and confirm eligibility via Check Eligibility for studies at University Hospital Lille. Explore the Contacts & Locations tab to access site-specific information and connect directly with study teams for enrollment inquiries.

Explore University Hospital Lille clinical trials

View 50 of 198 results.